Spineart is proud to announce that their cervical disc prosthesis BAGUERA®C has successfully been implanted more than 4.000 times worldwide. The first surgeries were held in January 2007 and as of today, the cervical disc prosthesis has been implanted in 20 countries on the 5 continents. BAGUERA®C is the first pre-assembled, MRI compatible prosthesis that is designed to absorb shocks with an artificial disc containing a guided mobile PE inlay.
Spineart extends its lumbar cages range in US. The FDA has granted 510k approval for the new transforminal oblique lumbar cage JULIET® OL. This cage, designed to share the load and improve the fusion process, is often associated with the minimally invasive surgery technique and complements the ROMEO®2 MIS system.
Spineart extends its ROMEO2 polyaxial screw in the US. The FDA has granted 510K approval for polyaxial screws diameter 4mm and 8mm. This supplement allows for thoracical lumbar constructs, revisions and more complex deformity cases. Spineart implants can now be used for long constructs.
SPINEART is proud to announce that since the first implantation in January 2007, their cervical disc prosthesis BAGUERA®C has successfully been implanted more than 3.500 times worldwide with very satisfying results. BAGUERA®C is the world’s first MRI compatible, pre-assembled, anatomical cervical artificial disc, designed to absorb shocks while containing a guided mobile PE inlay.
SPINEART has signed a distribution agreement with Sanofi-Aventis in Germany. Sanofi-Aventis, a leading global pharmaceutical company, is setting up a dedicated spine implant business to become one of the key players in the German spinal market, answering to the needs of the surgeons in the expected high quality manner. Germany is the biggest European market for spinal implants and the 3rd biggest market worldwide.
SPINEART has announced the 510k approval of their ROMEO® MIS lumbar minimally invasive system by the FDA in the United States. The system is designed to allow for minimally invasive as well as open surgery. It will also feature the possibilities of a percutaneous surgery, spondylolysthesis and fracture reduction.